Related Experiment Video
Updated: Mar 14, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
BPTF Depletion Enhances T-cell-Mediated Antitumor Immunity
Kimberly Mayes1, Suehyb G Alkhatib1, Kristen Peterson1
1Department of Human and Molecular Genetics, Virginia Institute of Molecular Medicine, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.
Abstract:
Genetic studies in fruit flies have implicated the chromatin remodeling complex nucleosome remodeling factor (NURF) in immunity, but it has yet to be studied in mammals. Here we show that its targeting in mice enhances antitumor immunity in two syngeneic models of cancer. NURF was disabled by silencing of bromodomain PHD-finger containing transcription factor (BPTF), the largest and essential subunit of NURF. We found that both CD8+ and CD4+ T cells were necessary for enhanced antitumor activity, with elevated numbers of activated CD8+ T cells observed in BPTF-deficient tumors. Enhanced cytolytic activity was observed for CD8+ T cells cocultured with BPTF-silenced cells. Similar effects were not produced with T-cell receptor transgenic CD8+ T cells, implicating the involvement of novel antigens. Accordingly, enhanced activity was observed for individual CD8+ T-cell clones from mice bearing BPTF-silenced tumors. Mechanistic investigations revealed that NURF directly regulated the expression of genes encoding immunoproteasome subunits Psmb8 and Psmb9 and the antigen transporter genes Tap1 and Tap2 The PSMB8 inhibitor ONX-0914 reversed the effects of BPTF ablation, consistent with a critical role for the immunoproteasome in improving tumor immunogenicity. Thus, NURF normally suppresses tumor antigenicity and its depletion improves antigen processing, CD8 T-cell cytotoxicity, and antitumor immunity, identifying NURF as a candidate therapeutic target to enhance antitumor immunity. Cancer Res; 76(21); 6183-92. ©2016 AACR.
Insights
Targeting the nucleosome remodeling factor (NURF) complex by disabling its bromodomain PHD-finger containing transcription factor (BPTF) subunit enhances antitumor immunity. This approach improves T-cell activity and antigen processing, suggesting NURF as a therapeutic target.
Area of Science:
- Immunology
- Cancer Research
- Chromatin Biology
Background:
- The nucleosome remodeling factor (NURF) complex, implicated in fruit fly immunity, has not been studied in mammalian systems.
- Understanding NURF's role in mammalian immunity is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the role of NURF in mammalian antitumor immunity.
- To determine if targeting NURF can enhance the immune response against cancer.
Main Methods:
- NURF was disabled in mice by silencing its essential subunit, bromodomain PHD-finger containing transcription factor (BPTF).
- Antitumor immunity was assessed in syngeneic cancer models using CD8+ and CD4+ T cell analysis.
- Mechanistic studies involved examining gene expression of immunoproteasome and antigen transporter components, and using a PSMB8 inhibitor.
Main Results:
- Disabling BPTF significantly enhanced antitumor immunity in mice.
- Elevated numbers of activated CD8+ T cells and enhanced cytolytic activity were observed in BPTF-deficient tumors, suggesting novel antigen involvement.
- NURF was found to directly regulate genes involved in antigen processing (Psmb8, Psmb9, Tap1, Tap2), and inhibition of PSMB8 reversed the enhanced immunity.
Conclusions:
- NURF normally suppresses tumor antigenicity; its depletion enhances antigen processing and CD8 T-cell cytotoxicity.
- Targeting NURF improves antitumor immunity, identifying it as a potential therapeutic target for cancer immunotherapy.
- The immunoproteasome plays a critical role in the enhanced antitumor immunity observed upon NURF ablation.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

